Home > Insider Trading > Filing (0001415889-22-012330)

Filing Details

Accession Number:: 0001415889-22-012330
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-09 16:48:08
Reporting Period:: 2022-12-07

Accepted Time:: 2022-12-09 16:48:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
842023	Bio-Techne Corp	TECH	Biological Products, (No Disgnostic Substances) (2836)	411427402

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1443851	S. Brenda Furlow	614 Mckinley Pl N E Minneapolis MN 55413	Svp - General Counsel	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-12-07	800	$31.26	26,892	No	4	M	Direct
Common Stock	Disposition	2022-12-07	800	$82.01	26,092	No	4	S	Direct
Common Stock	Acquisiton	2022-12-08	7,450	$31.26	33,542	No	4	M	Direct
Common Stock	Disposition	2022-12-08	7,450	$82.12	26,092	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2022-12-07	800	$0.00	800	$31.26
Common Stock	Stock Options (Right to Buy)	Disposition	2022-12-08	7,450	$0.00	7,450	$31.26

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
37,212		2024-08-09	No	4	M	Direct
29,762		2024-08-09	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,320	Indirect	By Trust #1
Common Stock	5,320	Indirect	By Trust #2

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (Right to Buy)	$44.33		2025-08-08	66,248	66,248	Direct
Common Stock	Stock Options (Right to Buy)	$47.60		2026-08-07	39,872	39,872	Direct
Common Stock	Stock Options (Right to Buy)	$47.60		2026-08-07	53,160	53,160	Direct
Common Stock	Restricted Stock Units	$0.00			6,716	6,716	Direct
Common Stock	Stock Options (Right to Buy)	$66.97		2027-08-05	29,968	29,968	Direct
Common Stock	Stock Options (Right to Buy)	$66.97		2027-08-05	39,960	39,960	Direct
Common Stock	Stock Options (Right to Buy)	$66.97		2027-08-05	0	0	Direct
Common Stock	Stock Options (Right to Buy)	$66.97		2027-08-05	33,300	33,300	Direct
Common Stock	Stock Options (Right to Buy)	$93.11	2022-08-31	2028-03-01	43,988	43,988	Direct
Common Stock	Restricted Stock Units	$0.00			4,668	4,668	Direct
Common Stock	Stock Options (Right to Buy)	$120.46		2028-08-06	18,240	18,240	Direct
Common Stock	Stock Options (Right to Buy)	$120.46		2028-08-06	24,320	24,320	Direct
Common Stock	Stock Options (Right to Buy)	$94.52		2029-08-15	24,664	24,664	Direct
Common Stock	Restricted Stock Units	$0.00			7,936	7,936	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2025-08-08	66,248	66,248	Direct
2026-08-07	39,872	39,872	Direct
2026-08-07	53,160	53,160	Direct
	6,716	6,716	Direct
2027-08-05	29,968	29,968	Direct
2027-08-05	39,960	39,960	Direct
2027-08-05	0	0	Direct
2027-08-05	33,300	33,300	Direct
2028-03-01	43,988	43,988	Direct
	4,668	4,668	Direct
2028-08-06	18,240	18,240	Direct
2028-08-06	24,320	24,320	Direct
2029-08-15	24,664	24,664	Direct
	7,936	7,936	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 82.0000 to 82.4900, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Fully exercisable.
Options to purchase13,292 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 13,288 shares vest on each of 8/7/2022 and 8/7/2023.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 9,992 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 9,988 shares vest on each of 8/5/2023 and 8/5/2024.
Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
Options to purchase 11,100 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 6,080 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
Options to purchase 6,168 shares vest on each of 8/15/2023 and 8/15/2025 and options to purchase 6,164 shares vest on 8/15/2024 and 8/15/2026.
2,644 shares vest on each of 8/15/2023 and 8/15/2025, and 2,648 shares vest on 8/15/2024.